loadpatents
name:-0.070446014404297
name:-0.056622982025146
name:-0.0035319328308105
Denny; William Alexander Patent Filings

Denny; William Alexander

Patent Applications and Registrations

Patent applications and USPTO patent grants for Denny; William Alexander.The latest application filed is for "tricyclic heterocyclic derivatives and uses thereof".

Company Profile
2.44.44
  • Denny; William Alexander - Auckland NZ
  • Denny; William Alexander - Manukau NZ
  • Denny; William Alexander - Manukai NZ
  • Denny; William Alexander - Aukland NZ
  • Denny; William Alexander - Pakuranga NZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic heterocyclic derivatives and uses thereof
Grant 11,028,064 - Gamage , et al. June 8, 2
2021-06-08
Tricyclic Heterocyclic Derivatives And Uses Thereof
App 20190276423 - GAMAGE; Swarnalatha Akuratiya ;   et al.
2019-09-12
Ketamine Derivatives
App 20190169113 - Sleigh; James Wallace ;   et al.
2019-06-06
Ketamine derivatives
Grant 10,239,825 - Sleigh , et al.
2019-03-26
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
Grant 9,896,443 - Spicer , et al. February 20, 2
2018-02-20
Ketamine Derivatives
App 20170190653 - Sleigh; James Wallace ;   et al.
2017-07-06
Kinase Inhibitors, Prodrug Forms Thereof And Their Use In Therapy
App 20160031877 - Smaill; Jeffrey Bruce ;   et al.
2016-02-04
Prodrug Forms Of Kinase Inhibitors And Their Use In Therapy
App 20160002222 - Smaill; Jeffrey Bruce ;   et al.
2016-01-07
Nitroimidazooxazines and their uses in anti-tubercular therapy
Grant 9,198,913 - Denny , et al. December 1, 2
2015-12-01
Ketamine Derivatives
App 20150259277 - Sleigh; James Wallace ;   et al.
2015-09-17
Kinase inhibitors, prodrug forms thereof and their use in therapy
Grant 9,101,632 - Smaill , et al. August 11, 2
2015-08-11
Perforin Inhibiting Benzenesulfonamide Compounds, Preparation And Uses Thereof
App 20150218150 - Spicer; Julie Ann ;   et al.
2015-08-06
Prodrug forms of kinase inhibitors and their use in therapy
Grant 9,073,916 - Smaill , et al. July 7, 2
2015-07-07
Compounds, Preparation And Uses Thereof
App 20130065897 - Spicer; Julie Ann ;   et al.
2013-03-14
Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
Grant 8,293,734 - Thompson , et al. October 23, 2
2012-10-23
Heteroaryl Benzamides, Compositions And Methods Of Use
App 20120225862 - Sutphin; Patrick D. ;   et al.
2012-09-06
Kinase Inhibitors, Prodrug Forms Thereof And Their Use In Therapy
App 20120202832 - Smaill; Jeffrey Bruce ;   et al.
2012-08-09
Prodrug Forms Of Kinase Inhibitors And Their Use In Therapy
App 20120077811 - Smaill; Jeffrey Bruce ;   et al.
2012-03-29
Nitroimidazooxazines And Their Uses In Anti-tubercular Therapy
App 20120028973 - Denny; William Alexander ;   et al.
2012-02-02
Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments
Grant 7,989,451 - Hay , et al. August 2, 2
2011-08-02
Substituted Pyrimidines And Triazines And Their Use In Cancer Therapy
App 20110053907 - Rewcastle; Gordon William ;   et al.
2011-03-03
Nitroimidazooxazine And Nitroimidazooxazole Analogues And Their Uses
App 20110028466 - Thompson; Andrew Mark ;   et al.
2011-02-03
1,2,4-benzotriazine-1,4-dioxides
Grant 7,816,521 - Denny , et al. October 19, 2
2010-10-19
Anti-inflammatory compounds
Grant 7,807,668 - Denny , et al. October 5, 2
2010-10-05
Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinases
Grant 7,786,131 - Bridges , et al. August 31, 2
2010-08-31
Nitroaniline-based alkylating agents and their use as prodrugs
Grant 7,776,924 - Denny , et al. August 17, 2
2010-08-17
Nitrobenzindoles and their use in cancer therapy
Grant 7,718,688 - Denny , et al. May 18, 2
2010-05-18
Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom
App 20100121091 - Atwell; Graham John ;   et al.
2010-05-13
Bicyclic nitroimidazole-substituted phenyl oxazolidinones
Grant 7,666,864 - Ding , et al. February 23, 2
2010-02-23
Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
App 20100010094 - Denny; William Alexander ;   et al.
2010-01-14
Substituted Ring Fused Azines And Their Use In Cancer Therapy
App 20090318479 - Denny; William Alexander ;   et al.
2009-12-24
Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
Grant 7,629,332 - Denny , et al. December 8, 2
2009-12-08
Bicyclic Nitroimidazole-substituted Phenyl Oxazolidinones
App 20090281088 - Ding; Charles Z. ;   et al.
2009-11-12
Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments
App 20090186886 - Hay; Michael Patrick ;   et al.
2009-07-23
Anti-tumour Polycyclic Carboxamides
App 20090156630 - Baguley; Bruce Charles ;   et al.
2009-06-18
Anti-tumour polycyclic carboxamides
Grant 7,504,507 - Baguley , et al. March 17, 2
2009-03-17
Nitrobenzindoles and Their use in Cancer Therapy
App 20080119442 - Denny; William Alexander ;   et al.
2008-05-22
Anti-Inflammatory Compounds
App 20070265253 - Denny; William Alexander ;   et al.
2007-11-15
Formulations of anthraquinone derivatives
Grant 7,276,537 - Denny , et al. October 2, 2
2007-10-02
Novel 1,2,4-benzotriazine-1,4-dioxides
App 20070197534 - Denny; William Alexander ;   et al.
2007-08-23
Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
App 20070191372 - Brown; J. Martin ;   et al.
2007-08-16
Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl-(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
Grant 7,235,578 - Denny , et al. June 26, 2
2007-06-26
Pteridinones As Kinase Inhibitors
App 20070049600 - Denny; William Alexander ;   et al.
2007-03-01
Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
App 20070032455 - Denny; William Alexander ;   et al.
2007-02-08
Pteridinones as kinase inhibitors
Grant 7,169,778 - Denny , et al. January 30, 2
2007-01-30
Pharmaceutical compounds
Grant 7,132,419 - Milton , et al. November 7, 2
2006-11-07
Formulations of anthraquinone derivatives
App 20060205820 - Denny; William Alexander ;   et al.
2006-09-14
Inhibitors of checkpoint kinases (Wee1 and Chk1)
Grant 7,094,798 - Booth , et al. August 22, 2
2006-08-22
Formulations of anthraquinone derivatives
Grant 7,074,835 - Denny , et al. July 11, 2
2006-07-11
Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
Grant 7,064,117 - Denny , et al. June 20, 2
2006-06-20
Nitroaniline-based alkylating agents and their use as prodrugs
App 20050256191 - Denny, William Alexander ;   et al.
2005-11-17
Formulations of anthraquinone derivatives
App 20050256188 - Denny, William Alexander ;   et al.
2005-11-17
Anti-tumour polycyclic carboxamides
App 20050245561 - Baguley, Bruce Charles ;   et al.
2005-11-03
5-substituted tetralones as inhibitors of ras farnesyl transferase
Grant 6,943,183 - Denny , et al. September 13, 2
2005-09-13
Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[rin- g fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom
App 20050148651 - Denny, William Alexander ;   et al.
2005-07-07
Pharmaceutical compounds
App 20050143383 - Milton, John ;   et al.
2005-06-30
Anti-cancer 2,3-dihydro-1H-pyrrole[3,2-f] quinoline compolexes of cobalt and chromium
App 20050038249 - Denny, William Alexander ;   et al.
2005-02-17
Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments
App 20040192686 - Wilson, William Robert ;   et al.
2004-09-30
Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f[quinoline complexes of cobalt and chromium
App 20040138195 - Denny, William Alexander ;   et al.
2004-07-15
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,713,484 - Bridges , et al. March 30, 2
2004-03-30
5- substituted tetralones as inhibitors of ras farnesyl trransferase
App 20040044057 - Denny, William Alexander ;   et al.
2004-03-04
Irreversible inhibitors of tyrosine kinases
App 20030229051 - Bridges, Alexander James ;   et al.
2003-12-11
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
App 20030186987 - Bridges, Alexander James ;   et al.
2003-10-02
Irreversible inhibitors of tyrosine kinases
Grant 6,602,863 - Bridges , et al. August 5, 2
2003-08-05
Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
App 20030139409 - Milton, John ;   et al.
2003-07-24
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,596,726 - Bridges , et al. July 22, 2
2003-07-22
Pteridinones as kinase inhibitors
App 20030130286 - Denny, William Alexander ;   et al.
2003-07-10
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,521,620 - Bridges , et al. Feb
2003-02-18
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,455,534 - Bridges , et al. Sept
2002-09-24
Irreversible inhibitors of tyrosine kinases
Grant 6,344,459 - Bridges , et al. Fe
2002-02-05
Pharmaceutical compounds
App 20010034346 - Milton, John ;   et al.
2001-10-25
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
App 20010027197 - Bridges, Alexander James ;   et al.
2001-10-04
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,265,410 - Bridges , et al.
2001-07-24
Seco precursors of cyclopropylindolines and their use as prodrugs
Grant 6,251,933 - Denny , et al. June 26, 2
2001-06-26
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
Grant 6,218,388 - Boschelli , et al. April 17, 2
2001-04-17
Enediyne compounds
Grant 6,124,310 - Denny , et al. September 26, 2
2000-09-26
Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 6,084,095 - Bridges , et al.
2000-07-04
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
Grant 5,990,146 - Boschelli , et al. November 23, 1
1999-11-23
Cyclopropylindoles and their seco precursors, and their use as prodrugs
Grant 5,985,909 - Denny , et al. November 16, 1
1999-11-16
Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
Grant 5,872,129 - Denny , et al. February 16, 1
1999-02-16
Treatment of cancers
Grant 5,696,131 - Baguley , et al. December 9, 1
1997-12-09
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 5,679,683 - Bridges , et al. Oc
1997-10-21
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
Grant 5,654,307 - Bridges , et al.
1997-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed